Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134711) titled 'Efficacy and Safety of Low-dose Thoracic Radiotherapy Followed by Adebrelimab Plus Chemotherapy and Sequential Adebrelimab Maintenance Therapy for Extensive-stage Small Cell Lung Cancer: A Prospective, Multicenter Phase II Study' on Oct. 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Jiangmen Central Hospital
Condition:
Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2026-07-20
Target Sample Size: Experimental group:43;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showp...